Can ketamine help new moms after C-Section? early study suspended

NCT ID NCT06767566

Terminated Knowledge-focused Sponsor: University of Utah Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 30, 2026 · Updated 4 times

Summary

This Phase 1 study aims to understand how the body processes ketamine after a cesarean delivery, and whether it can help with postpartum depression and pain. Fifty participants will receive a low-dose ketamine infusion, and researchers will measure drug levels and side effects. The study is currently suspended, and its main goal is to gather information, not to prove a cure.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Ketamine (Ketalar)
What this could lead to: If successful, this study could help doctors understand how to use ketamine more effectively for postpartum depression and pain after cesarean delivery.
What could go wrong: This is a very early Phase 1 study with only 50 participants. It is currently suspended, and its main goal is to measure drug levels, not to prove treatment effectiveness. Side effects from ketamine are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PAIN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Pain postpartum depression

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PAIN POSTPARTUM DEPRESSION

Contacts and locations

Locations

Magee Womens Hospital of UPMC

Pittsburgh, Pennsylvania, 15213, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.